HHHuaiqiu Huang

Huaiqiu Huang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Huaiqiu Huang has a total of 238 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    In Silico Screening Identifies Pseudoprotodioscin as a Potential Antifungal Agent Against Multidrug-Resistant Candida auris

    by Yuzhe Li, Baicheng Deng, Weilai Teng, Jinping Lei, Huaiqiu Huang

    Candidozyma auris is an emerging multidrug-resistant fungal pathogen with very limited treatment options, posing a severe global threat. This study aimed to screen natural-product-derived inhibitors against multidrug-resistant C. auris. We compared transcriptomic datasets of drug-resistant and susceptible C. auris strains from public databases to identify shared differentially expressed genes across three distinct antifungal-resistance backgrounds. The pH-responsive gene 1 (PHR1) and lipase 1 (LIP1) were prioritized as molecular targets for further investigation. We then performed virtual screening from a natural-product library and applied molecular-dynamics simulations to assess target–ligand binding stability. Pseudoprotodioscin (PPD) and Corylifol A (CYA) were selected as candidate agents. Subsequent in vitro experiments were conducted to evaluate their antifungal potency. Our results showed that PPD exhibited promising antifungal activity and produced synergistic effects in combination with fluconazole. In conclusion, this study suggests that the natural product PPD obtained via computer-aided screening may underpin the development of innovative antifungals against multidrug-resistant C. auris.

  • Open Access

    SgtrCypB Formulated with Freund’s Adjuvant Confers Protective Immunity Against S. globosa and Partial Cross-Protection Against S. schenckii Infections in Mice

    by Ling Hu, Baicheng Deng, Yuyan Hong, Meizhen Zhong, Xiaoyu Zhi, Xuchu Hu, Huaiqiu Huang

    Sporothrix globosa is the predominant cause of sporotrichosis in China, highlighting the need for effective vaccine strategies. Cyclophilins from pathogenic microorganisms have emerged as potential vaccine antigens. We previously generated a high-yield, high-purity recombinant truncated S. globosa cyclophilin B protein (SgtrCypB) retaining its functional domain. Here, BALB/c mice were immunized subcutaneously with SgtrCypB alone or formulated with Freund’s adjuvant to evaluate immunogenicity. Only the adjuvant-formulated vaccine induced a high antibody titer (1:51,200). Then, the infection-challenge experiments compared the SgtrCypB formulated with Freund’s adjuvant and PBS formulated with Freund’s adjuvant groups. Following challenge, SgtrCypB plus adjuvant reduced cutaneous lesion size (0.6 vs. 1.0 cm at week 1) without significantly affecting ulcer incidence. In systemic S. globosa infection, vaccination increased survival to 90% versus 40% in controls and reduced organ fungal burdens. Partial cross-protection was observed against S. schenckii, with 60% versus 20% survival and lower fungal burdens in the kidneys and lungs. Protection against C. albicans was minimal. These findings identify SgtrCypB as a promising protective antigen against S. globosa and S. schenckii and support further evaluation with clinically applicable adjuvants.

  • Open Access

    Rapid Detection of Fungi in Nail Specimens Using Multi‐Tube Recombinase Polymerase Amplification Assay

    by Rong Wu, Meirong Li, Weian Du, Zetao Chen, Songchao Yin, Ling Hu, Liyan Xi, Jing Zhang, Huaiqiu Huang

    Background: Conventional diagnostic methods for onychomycosis possess disadvantages related to limited sensitivity, extended turnaround times and strong reliance on operator expertise. Objectives: To develop a molecular assay with high sensitivity and specificity for rapid detection of multiple fungal pathogens in nail specimens. Methods: A multi‐tube recombinase polymerase amplification (RPA) assay with fluorescent signal detection was developed, targeting pan‐fungal, Trichophyton rubrum , T. interdigitale , pan‐ Candida , Candida albicans , pan‐ Trichosporon and pan‐ Aspergillus . The analytical sensitivity and specificity of the assay were evaluated using fungal strains, and its performance was assessed in 81 clinical nail specimens in parallel with calcofluor white fluorescence microscopy and fungal culture. Results: The multi‐tube RPA assay demonstrated a detection limit of 1 pg of genomic DNA for all targets, with a turnaround time of < 70 min. In the evaluation of 81 clinical nail specimens, Bayesian latent class analysis estimated sensitivities of 86.0% for multi‐tube RPA, 67.0% for fungal culture and 77.0% for microscopy, with corresponding specificities of 85.0%, 89.0% and 87.0%. The positive and negative predictive values were 92.0% and 72.0% for multi‐tube RPA, 93.0% and 55.0% for fungal culture, and 93.0% and 66.0% for microscopy. Conclusion: Compared with fungal culture and microscopy, the multi‐tube RPA assay demonstrated superior sensitivity while maintaining good specificity, facilitating the identification of fungal pathogens at the species level in nail specimens. Its operational simplicity, enhanced diagnostic performance and reduced processing times make it a promising alternative for the mycological diagnosis of onychomycosis.


  • Open Access

    D-lactic acid inhibits Candida albicans associated with vulvovaginal candidiasis: in vitro and in vivo effects and underlying mechanisms

    by Tingting Xia, Shujun Su, Rong Wu, Miaorong Zhan, Xuchu Hu, Huaiqiu Huang

    Candida albicans (C. albicans) is a major opportunistic fungal pathogen responsible for both invasive and superficial infections, including vulvovaginal ca


  • Open Access

    Relationship between Platelets, Plateletcrit and Lymphocytes in the Complete Blood Count and Recurrent Implantation Failure: A Retrospective Study

    by Xiao Liu, Jianping Ou, Huaiqiu Huang, Tingting Xia

    Background: Approximately 10% of women undergoing in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) treatment experience recurrent implantation failure (RIF). The causes for RIF are complicated. Inflammatory processes and thrombophilia play important roles in the development of RIF. This retrospective study was conducted to investigate whether there is an association between inflammatory parameters, including platelets (PLTs), plateletcrit (PCT) and lymphocytes in the complete blood count (CBC) and RIF. Methods: This was a single-center retrospective evaluation of 150 women who had a history of RIF and 163 controls who had a live birth after the first embryo transfer. Basal characteristics, CBC and coagulation parameters of both groups were compared. Results: Compared with the controls, the women with a history of RIF had significantly lower PLT, PCT and lymphocyte counts (p = 0.03, p = 0.019 and p = 0.012, respectively). Receiver operating characteristic curve analysis revealed that PLT had a sensitivity of 48.6% and a specificity of 66.4% with a cutoff value of 271.5 (area under the curve (AUC): 0.575); PCT had a sensitivity of 77% and a specificity of 38.9% with a cutoff value of 0.245 (AUC: 0.575); and lymphocyte count had a sensitivity of 49.3% and a specificity of 71% with a cutoff value of 2.015 (AUC: 0.577) for predicting RIF. The multivariant receiver operating characteristic (ROC) analysis revealed a cutoff value of 0.508 with a sensitivity of 70.3% and a specificity of 48.9% (AUC: 0.599) (p = 0.004). Conclusions: PLT, PCT and lymphocyte counts in patients with RIF are significantly reduced, although they are not effective parameters for predicting RIF.


  • Open Access

    Predicting drug–Protein interaction with deep learning framework for molecular graphs and sequences: Potential candidates against SAR-CoV-2

    by Weian Du, Liang Zhao, Rong Wu, Boning Huang, Si Liu, Yufeng Liu, Huaiqiu Huang, Ge Shi

    The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused the COVID-19 disease, which represents a new life-threatening disaster. Regarding viral infection, many therapeutics have been investigated to alleviate the epidemiology such as vaccines and receptor decoys. However, the continuous mutating coronavirus, especially the variants of Delta and Omicron, are tended to invalidate the therapeutic biological product. Thus, it is necessary to develop molecular entities as broad-spectrum antiviral drugs. Coronavirus replication is controlled by the viral 3-chymotrypsin-like cysteine protease (3CLpro) enzyme, which is required for the virus’s life cycle. In the cases of severe acute respiratory syndrome coronavirus (SARS-CoV) and middle east respiratory syndrome coronavirus (MERS-CoV), 3CLpro has been shown to be a promising therapeutic development target. Here we proposed an attention-based deep learning framework for molecular graphs and sequences, training from the BindingDB 3CLpro dataset (114,555 compounds). After construction of such model, we conducted large-scale screening the in vivo/vitro dataset (276,003 compounds) from Zinc Database and visualize the candidate compounds with attention score. geometric-based affinity prediction was employed for validation. Finally, we established a 3CLpro-specific deep learning framework, namely GraphDPI-3CL (AUROC: 0.958) achieved superior performance beyond the existing state of the art model and discovered 10 molecules with a high binding affinity of 3CLpro and superior binding mode.


  • Open Access

    Optimized expression of Peptidyl-prolyl cis/transisomerase cyclophilinB with prokaryotic toxicity from Sporothrix globosa

    by Ling Hu, Baicheng Deng, Rong Wu, Miaorong Zhan, Xuchu Hu, Huaiqiu Huang

    Cyclophilin B (CypB), a significant member of immunophilins family with peptidyl-prolyl cis-trans isomerase (PPIase) activity, is crucial for the growth and metabolism of prokaryotes and eukaryotes. Sporothrix globosa (S. globosa), a principal pathogen in the Sporothrix complex, causes sporotrichosis. Transcriptomic analysis identified the cypB gene as highly expressed in S. globosa. Our previous study demonstrated that the recombinant Escherichia coli strain containing SgcypB gene failed to produce sufficient product when it was induced to express the protein, implying the potential toxicity of recombinant protein to the bacterial host. Bioinformatics analysis revealed that SgCypB contains transmembrane peptides within the 52 amino acid residues at the N-terminus and 21 amino acids near the C-terminus, and 18 amino acid residues within the cytoplasm. AlphaFold2 predicted a SgCypB 3D structure in which there is an independent PPIase domain consisting of a spherical extracellular part. Hence, we chose to express the extracellular domain to yield high-level recombinant protein with PPIase activity. Finally, we successfully produced high-yield, truncated recombinant CypB protein from S. globosa (SgtrCypB) that retained characteristic PPIase activity without host bacterium toxicity. This study presents an alternative expression strategy for proteins toxic to prokaryotes, such as SgCypB. The recombinant cyclophilin B protein of Sporothrix globosa was expressed successfully by retaining extracellular domain with peptidyl-prolyl cis-trans isomerase activity to avoid toxicity to the host bacterium.


  • Open Access

    Long-read PacBio genome sequencing of four environmental saprophytic Sporothrix species spanning the pathogenic clade

    by Weian Du, Domenico Giosa, Junkang Wei, Letterio Giuffrè, Ge Shi, Lamya El Aamri, Enrico D’aLessandro, Majida Hafidi, Sybren de Hoog, Orazio Romeo, et al.

    Background: The genus Sporothrix belongs to the order Ophiostomatales and contains mainly saprobic soil and plant fungi, although pathogenic species capable of causing human infections are also present. The whole-genomes of disease-causing species have already been sequenced and annotated but no comprehensive genomic resources for environmental Sporothrix species are available, thus limiting our understanding of the evolutionary origin of virulence-related genes and pathogenicity. Result: The genome assembly of four environmental Sporothrix species resulted in genome size of ~ 30.9 Mbp in Sporothrix phasma, ~ 35 Mbp in S. curviconia, ~ 38.7 Mbp in S. protearum, and ~ 39 Mbp in S. variecibatus, with a variable gene content, ranging from 8142 (S. phasma) to 9502 (S. variecibatus). The analysis of mobile genetic elements showed significant differences in the content of transposable elements within the sequenced genomes, with the genome of S. phasma lacking several class I and class II transposons, compared to the other Sporothrix genomes investigated. Moreover, the comparative analysis of orthologous genes shared by clinical and environmental Sporothrix genomes revealed the presence of 3622 orthogroups shared by all species, whereas over 4200 genes were species-specific single-copy gene products. Carbohydrate-active enzyme analysis revealed a total of 2608 protein-coding genes containing single and/or multiple CAZy domains, resulting in no statistically significant differences among pathogenic and environmental species. Nevertheless, some families were not found in clinical species. Furthermore, for each sequenced Sporothrix species, the mitochondrial genomes was assembled in a single circular DNA molecule, ranging from 25,765 bp (S. variecibatus) to 58,395 bp (S. phasma). Conclusion: In this study, we present four annotated genome assemblies generated using PacBio SMRT sequencing data from four environmental species: S. curviconia, S. phasma, S. protearum and S. variecibatus with the aim to provide a starting point for future comparative genome evolution studies addressing species diversification, ecological/host adaptation and origin of pathogenic lineages within the genus Sporothrix.


  • Open Access

    Chitin-rich heteroglycan from Sporothrix schenckii sensu stricto potentiates fungal clearance in a mouse model of sporotrichosis and promotes macrophages phagocytosis

    by Lilin Huang, Jing Zhang, Weian Du, Zixian Liang, Meirong Li, Rong Wu, Sanmei Chen, Xuchu Hu, Huaiqiu Huang

    Background: Fungal cell wall polysaccharides maintain the integrity of fungi and interact with host immune cells. The immunomodulation of fungal polysaccharides has been demonstrated in previous studies. However, the effect of chitin-rich heteroglycan extracted fromSporothrix schenckiisensu strictoon the immune response has not been investigated.Results: In this study, chitin-rich heteroglycan was extracted fromS. schenckiisensu stricto, and immunomodulation was investigated via histopathological analysis of skin lesions in a mouse model of sporotrichosis and evaluation of the phagocytic function and cytokine secretion of macrophages in vitro. The results showed that the skin lesions regressed and granulomatous inflammation was reduced in infected mice within 5 weeks. Moreover, heteroglycan promoted the fungal phagocytosis by macrophages and modulated the cytokine secretion. Heteroglycan upregulated TNF-α expression early at 24 h and IL-12 expression late at 72 h after incubation, which might result from moderate activation of macrophages and contribute to the subsequent adaptive immune response.Conclusions: Chitin-rich heteroglycan extracted fromS. schenckiisensu strictopotentiated fungal clearance in a mouse model of sporotrichosis. Moreover, chitin-rich heteroglycan promoted fungus phagocytosis by macrophages and modulated cytokines secretion. These results might indicate that chitin-rich heteroglycan could be considered as an immunomodulator used in the treatment of sporotrichosis.


  • Open Access

    China Consensus Document on Allergy Diagnostics

    by Hao Chen, Jing Li, Lei Cheng, Zhongshan Gao, Xiaoping Lin, Rongfei Zhu, Lin Yang, Ailin Tao, Haiyu Hong, Wei Tang, et al.

    Chen H, et al. Allergy Asthma Immunol Res. 2021 Mar;13(2):177-205. https://doi.org/10.4168/aair.2021.13.2.177